Catherine Zabkiewicz1, Jeyna Resaul1, Rachel Hargest1, Wen Guo Jiang2, Lin Ye2. 1. Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff, U.K. 2. Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff, U.K. Yel@Cardiff.ac.uk JiangWG@Cardiff.ac.uk.
Abstract
BACKGROUND/AIM: Activin and its antagonist follistatin (FST) have been implicated in several solid tumours. This study investigated the role of FST in breast cancer. MATERIALS AND METHODS: FST expression was examined using reverse transcription polymerase chain reaction (RT-PCR), real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry in a cohort of breast cancer samples. Expression was correlated to pathological and prognostic parameters in our patient cohort. FST was overexpressed in MCF-7 cells and assays for growth and invasion were performed. RESULTS: FST is expressed in breast tissue, in the cytoplasm of mammary epithelial cells. Expression was decreased in breast cancer tissue in comparison to normal mammary tissue. Over-expression of FST in vitro led to significantly increased growth rate and reduced invasion. Higher FST associates with lower-grade tumours and better survival. CONCLUSION: Our results suggest a role for FST as a suppressor of invasion and metastasis in breast cancer. Copyright
BACKGROUND/AIM: Activin and its antagonist follistatin (FST) have been implicated in several solid tumours. This study investigated the role of FST in breast cancer. MATERIALS AND METHODS:FST expression was examined using reverse transcription polymerase chain reaction (RT-PCR), real-time quantitative polymerase chain reaction (qPCR) and immunohistochemistry in a cohort of breast cancer samples. Expression was correlated to pathological and prognostic parameters in our patient cohort. FST was overexpressed in MCF-7 cells and assays for growth and invasion were performed. RESULTS:FST is expressed in breast tissue, in the cytoplasm of mammary epithelial cells. Expression was decreased in breast cancer tissue in comparison to normal mammary tissue. Over-expression of FST in vitro led to significantly increased growth rate and reduced invasion. Higher FST associates with lower-grade tumours and better survival. CONCLUSION: Our results suggest a role for FST as a suppressor of invasion and metastasis in breast cancer. Copyright
Authors: Joanna E Burdette; Jacqueline S Jeruss; Sarah J Kurley; Eun Jig Lee; Teresa K Woodruff Journal: Cancer Res Date: 2005-09-01 Impact factor: 12.701
Authors: Jelena Krneta; Jens Kroll; Frauke Alves; Claudia Prahst; Farahnaz Sananbenesi; Christian Dullin; Sarah Kimmina; David J Phillips; Hellmut G Augustin Journal: Cancer Res Date: 2006-06-01 Impact factor: 12.701
Authors: Hendrik Nogai; Mark Rosowski; Joachim Grün; Anika Rietz; Nils Debus; Gül Schmidt; Carola Lauster; Michal Janitz; Andrea Vortkamp; Roland Lauster Journal: Differentiation Date: 2007-11-20 Impact factor: 3.880
Authors: Enrrico Bloise; Henrique L Couto; Lauretta Massai; Pasquapina Ciarmela; Marzia Mencarelli; Lavinia E Borges; Michela Muscettola; Giovanni Grasso; Vania F Amaral; Geovanni D Cassali; Felice Petraglia; Fernando M Reis Journal: BMC Cancer Date: 2009-09-09 Impact factor: 4.430
Authors: Max M Gong; Karina M Lugo-Cintron; Bridget R White; Sheena C Kerr; Paul M Harari; David J Beebe Journal: Biomaterials Date: 2019-05-25 Impact factor: 12.479
Authors: Stephanie Tuminello; Yian Zhang; Lei Yang; Nedim Durmus; Matija Snuderl; Adriana Heguy; Anne Zeleniuch-Jacquotte; Yu Chen; Yongzhao Shao; Joan Reibman; Alan A Arslan Journal: Int J Environ Res Public Health Date: 2022-04-22 Impact factor: 4.614